Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Long-Term Investments (2019 - 2025)

Cellectis has reported Long-Term Investments over the past 7 years, most recently at $5.1 million for Q4 2025.

  • Quarterly results put Long-Term Investments at $5.1 million for Q4 2025, down 32.35% from a year ago — trailing twelve months through Dec 2025 was $5.1 million (down 32.35% YoY), and the annual figure for FY2025 was $5.1 million, down 32.35%.
  • Long-Term Investments for Q4 2025 was $5.1 million at Cellectis, down from $7.5 million in the prior quarter.
  • Over the last five years, Long-Term Investments for CLLS hit a ceiling of $8.1 million in Q4 2022 and a floor of $1.0 million in Q4 2021.
  • Median Long-Term Investments over the past 5 years was $7.5 million (2024), compared with a mean of $5.9 million.
  • Biggest five-year swings in Long-Term Investments: skyrocketed 710.0% in 2022 and later plummeted 32.35% in 2025.
  • Cellectis' Long-Term Investments stood at $1.0 million in 2021, then skyrocketed by 710.0% to $8.1 million in 2022, then decreased by 3.05% to $7.9 million in 2023, then fell by 4.23% to $7.5 million in 2024, then crashed by 32.35% to $5.1 million in 2025.
  • The last three reported values for Long-Term Investments were $5.1 million (Q4 2025), $7.5 million (Q4 2024), and $7.9 million (Q4 2023) per Business Quant data.